Mass spectrometric methods for detecting mutations in a target nucleic acid
First Claim
Patent Images
1. A process for characterizing a target nucleic acid from a biological sample, comprising:
- a) amplifying a target nucleic acid from a biological sample by polymerase chain reaction (PCR);
b) ionizing and volatilizing the product of step (a); and
c) analyzing (i) a forward strand PCR product by mass spectrometry to determine an observed molecular mass of the forward strand PCR product, or (ii) analyzing a reverse strand PCR product by mass spectrometry to determine an observed molecular mass of the reverse strand PCR product;
whereby the target nucleic acid is characterized based on the analysis of (c).
3 Assignments
0 Petitions
Accused Products
Abstract
Fast and highly accurate mass spectrometry-based processes for detecting particular nucleic acid molecules and mutations in the molecules are provided. In some embodiments, a process comprises: amplifying one or more target nucleic acid molecules from a biological sample; ionizing and volatilizing the amplified product; and analyzing a product by mass spectrometry to determine an observed molecular mass of the product.
389 Citations
47 Claims
-
1. A process for characterizing a target nucleic acid from a biological sample, comprising:
-
a) amplifying a target nucleic acid from a biological sample by polymerase chain reaction (PCR); b) ionizing and volatilizing the product of step (a); and c) analyzing (i) a forward strand PCR product by mass spectrometry to determine an observed molecular mass of the forward strand PCR product, or (ii) analyzing a reverse strand PCR product by mass spectrometry to determine an observed molecular mass of the reverse strand PCR product; whereby the target nucleic acid is characterized based on the analysis of (c). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 44, 45)
-
-
23. A process for characterizing a target nucleic acid from a biological sample, comprising:
-
a) providing a biological sample; b) isolating a target nucleic acid from the biological sample; c) amplifying the target nucleic acid of (b) by polymerase chain reaction (PCR); d) ionizing and volatilizing the product of step (c); and e) analyzing (i) a forward strand PCR product by mass spectrometry to determine an observed molecular mass of the forward strand PCR product, or (ii) analyzing a reverse strand PCR product by mass spectrometry to determine an observed molecular mass of the reverse strand PCR product; whereby the target nucleic acid is characterized based on the analysis of (e). - View Dependent Claims (24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 46, 47)
-
Specification